Lymphocyte Signaling
Thioredoxin 1 Blocking Peptide
|
イイネ!(0)
|
|
| CSTコード |
包装 |
希望納入価格 (円) |
国内在庫  |
ご登録代理店情報  カスタマー情報にご登録いただいた代理店を表示しています。
ご登録代理店の変更は こちら。 |
| #1057S | 100 μg | 16,000 | |
|
Thioredoxin抗体製品一覧
| 使用目的 | |
| Thioredoxin 1 (C63C6) Rabbit mAb (#2429) の反応をブロックし、抗体の反応特異性を確認するために使用 |
IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded breast carcinoma tissue using Thioredoxin 1 (C63C6) Rabbit mAb #2429 in the presence of control peptide (left) or Thioredoxin 1 Blocking Peptide (right).
Thioredoxin is a small redox protein found in many eukaryotes and prokaryotes. A pair of cysteines within a highly conserved, active site sequence can be oxidized to form a disulfide bond which is then reduced by thioredoxin reductase (1). Multiple forms of thioredoxin have been identified, including cytosolic thioredoxin 1 (Trx1) and mitochondrial thioredoxin 2 (Trx2). Thioredoxin participates in many cellular processes including redox signaling, response to oxidative stress and protein reduction (1). A potential role of thioredoxin in human disorders such as cancer, aging and heart disease is currently under investigation (2). Thioredoxin can play a key role in cancer progression, as it acts as a negative regulator of the proapoptotic kinase ASK1 (3) Changes in thioredoxin expression have been associated with meningococcal septic shock and acute lung injury (4,5).
-
Watson, W.H. et al. (2004) Toxicol. Sci. 78, 3-14.
-
Burke-Gaffney, A. et al. (2005) Trends Pharmacol. Sci. 26, 398-404.
-
Saitoh, M. et al. (1998) EMBO J. 17, 2596-2606.
-
Callister, M.E. et al. (2007) Intensive Care Med. 33, 364-367.
-
Callister, M.E. et al. (2006) Thorax 61, 521-527.